Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2022 ∙ Goulden, B. Chua, N. Parker, E. Giles, I.
A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero
Newborn Tuberculosis Rotavirus Safety
Rating:
Critically low
2022 ∙ Chua, N. Parker, E. Giles, I. Goulden, B.
A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic medications (DMARDs) in-utero
Newborn Tuberculosis Mumps Measles Rubella Rotavirus Safety Administration
Rating:
Critically low
2022 ∙ Teerawattananon, Y. Anothaisintawee, T. Pheerapanyawaranun, C. Botwright, S. Akksilp, K. Sirichumroonwit, N. Budtarad, N. Isaranuwatchai, W.
A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings
All age groups Healthcare workers Low and Middle Income Countries COVID-19 Efficacy/effectiveness
Rating:
Not applicable
2022 ∙ Saluja, P. Amisha, F. Gautam, N. Goraya, H.
A Systematic Review of Reported Cases of Immune Thrombocytopenia after COVID-19 Vaccination
Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Elberry, M. H. Abdelgawad, H. A. H. Hamdallah, A. Abdella, W. S. Ahmed, A. S. Ghaith, H. S. Negida, A.
A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines
Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Kalantari, Y. Aryanian, Z. Mirahmadi, S. M. Alilou, S. Hatami, P. Goodarzi, A.
A systematic review on COVID-19 vaccination and cosmetic filler reactions: A focus on case studies and original articles
Adults Older adults COVID-19 Safety Administration
Rating:
Critically low
2022 ∙ Seirafianpour, F. Pourriyahi, H. Mesgarha, M. G. Pour Mohammad, A. Shaka, Z. Goodarzi, A.
A systematic review on mucocutaneous presentations after COVD-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders
All age groups COVID-19 Safety Administration
Rating:
Critically low
2022 ∙ Cénat, J. M. Noorishad, P. G. Bakombo, S. M. Onesi, O. Mesbahi, A. Darius, W. P. Caulley, L. Yaya, S. Chomienne, M. H. Etowa, J. Venkatesh, V. Dalexis, R. D. Pongou, R. Labelle, P. R.
A Systematic Review on Vaccine Hesitancy in Black Communities in Canada: Critical Issues and Research Failures
Americas Canada Adults Older adults COVID-19 Acceptance Ethical issues
Rating:
Not applicable
2022 ∙ Tan, L. J. Koh, C. P. Lai, S. K. Poh, W. C. Othman, M. S. Hussin, H.
A systemic review and recommendation for an autopsy approach to death followed the COVID 19 vaccination
Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Wang, D. Wu, J. Du, J. Ong, H. Tang, B. Dozier, M. Weller, D. Campbell, C.
Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature
Western Pacific China Adolescents Adults Older adults Healthcare workers Parents/caregivers Human papillomavirus (HPV) Acceptance
Rating:
Not applicable
Loading...